-
公开(公告)号:US20240307235A1
公开(公告)日:2024-09-19
申请号:US18673408
申请日:2024-05-24
Applicant: Solventum Intellectual Properties Company
Inventor: Christopher Brian LOCKE , Timothy Mark Robinson
Abstract: A dressing for treating a tissue site with negative pressure may comprise a first polymer film having a plurality of fluid restrictions, and a second polymer film comprising a plurality of standoffs disposed adjacent to the first polymer film. The first polymer film and the second polymer film may be substantially transparent to allow observation of the tissue site. In some embodiments, at least some of the standoffs may be offset from the fluid restrictions. The second polymer film may comprise fluid passages adjacent to the standoffs in some examples.
-
2.
公开(公告)号:US20240285844A1
公开(公告)日:2024-08-29
申请号:US18653691
申请日:2024-05-02
Applicant: T.J.Smith and Nephew,Limited
Inventor: Felix Clarence Quintanar
IPC: A61M1/00
CPC classification number: A61M1/73 , A61M1/915 , A61M1/92 , A61M1/96 , A61M1/985 , A61M1/74 , A61M1/982 , A61M2205/15 , A61M2205/18 , A61M2205/3331 , A61M2205/3382
Abstract: Embodiments of apparatuses and methods for providing negative pressure wound therapy to multiple wounds are disclosed. In some embodiments, presence of blockage in one or more fluid flow paths connecting a negative pressure source to one or more dressings can be performed. Determination of a blockage can be performed based on comparing one or more pressure measurements to at least one threshold. The at least one threshold can be determined based on detected capacities of the one or more dressings.
-
公开(公告)号:US20240123135A1
公开(公告)日:2024-04-18
申请号:US18277494
申请日:2022-01-20
Applicant: KCI Manufacturing Unlimited Company
Inventor: Jonathan G. REHBEIN , Javier GONZALEZ
Abstract: Some embodiments of a manifold pad may be configured to distribute reduced pressure relative to a tissue site and to provide instillation to the tissue site. In some embodiments, the manifold pad may comprise open-cell foam and at least one skinned channel extending through the open-cell foam. The at least one skinned channel may be configured so that the skin is substantially impermeable to liquid, preventing liquid within the channel from seeping into the open-cell foam. In some embodiments, this may allow for two isolated pathways for fluid movement through the manifold pad. Some dressing embodiments may utilize such a manifold pad in conjunction with a treatment device. Other apparatus, dressings, systems, and methods are disclosed.
-
公开(公告)号:US11911556B2
公开(公告)日:2024-02-27
申请号:US16891594
申请日:2020-06-03
Applicant: KCI Licensing, Inc.
Inventor: David Richard Mercer , Christopher Brian Locke , Benjamin Andrew Pratt
CPC classification number: A61M1/92 , A61M1/77 , A61M1/85 , A61M1/915 , A61M3/0254 , A61M1/916 , A61M2205/15 , A61M2205/18 , A61M2205/583 , A61M2205/8206 , A61M2207/00 , A61M2210/1021
Abstract: Some illustrative embodiments of an instillation assembly for treating a tissue site may include a fluid distribution lumen and a fluid hub that may define a fluid instillation pathway. The fluid distribution lumen may be defined by a first film layer and a second film layer, and the fluid hub may be positioned in fluid communication with the fluid distribution lumen. The instillation assembly may be used in combination with a reduced-pressure assembly that may define a reduced-pressure pathway separate from the fluid instillation pathway.
-
公开(公告)号:US11883578B2
公开(公告)日:2024-01-30
申请号:US16168426
申请日:2018-10-23
Applicant: KCI Licensing, Inc.
Inventor: Christopher Brian Locke , Thomas Edwards
CPC classification number: A61M1/73 , A61F13/00068 , A61F13/0216 , A61M1/90 , A61M1/913 , A61M1/915 , A61M1/92 , A61M1/966 , A61F13/0223 , A61F2013/00536 , A61M1/74 , A61M2205/3344
Abstract: Systems, apparatuses, and methods for providing negative pressure to a tissue site are disclosed. Illustrative embodiments may include an apparatus or system for delivering negative-pressure to a tissue site, which can be used in conjunction with low-profile distribution components for wound therapy. Such apparatus may include a low-profile dressing interface or connector comprising at least two side-by-side fluid pathways fluidly coupled to a recessed space of the connector, one for providing negative pressure to a tissue interface or manifold and the other for sensing the negative pressure within the recessed space adjacent the tissue interface. In some embodiments, for example, the apparatus may comprise a first layer of polymeric film having an outer surface, an inner surface, and a plurality of features extending from the inner surface, and a second layer of polymeric film coupled to the first layer. The second layer may have an outer, tissue-facing surface and an inner surface coupled to the first layer and covering the plurality of features to form an enclosed space with the inner surface of the first layer and a plurality of flow channels within the enclosed space. The second layer also includes an aperture defining the recessed space adapted to fluidly coupling the enclosed space to the tissue interface.
-
公开(公告)号:US11883263B2
公开(公告)日:2024-01-30
申请号:US16678292
申请日:2019-11-08
Applicant: KCI Licensing, Inc.
Inventor: Justin Rice , Christopher Allen Carroll , Shannon C. Ingram
CPC classification number: A61F13/00068 , A61B17/32 , A61F13/02 , A61M1/915 , A61F2013/00174 , A61F2013/00327 , A61M1/85 , A61M1/92
Abstract: A dressing that includes a contact layer having walls defining a plurality of holes and a retainer layer comprising portions protruding into holes of a contact layer is provided herein. Systems, methods and kits using the dressing for debriding a tissue site are also provided herein.
-
公开(公告)号:US11865280B2
公开(公告)日:2024-01-09
申请号:US17125307
申请日:2020-12-17
Applicant: KCI Licensing, Inc.
Inventor: Bruce McNeil
CPC classification number: A61M27/00 , A61F13/00068 , A61F13/0216 , A61M1/913 , A61M1/915 , A61M1/92
Abstract: A reduced-pressure treatment system for applying reduced pressure to a tissue site at a limited-access location on a patient includes a reduced-pressure source, a treatment manifold for placing proximate the tissue site and operable to distribute reduced pressure to the tissue site, and a sealing member for placing over the tissue site and operable to form a pneumatic seal over the tissue site. The reduced-pressure treatment system also includes a reduced-pressure bridge and a moisture-removing device on at least portion of the reduced-pressure bridge. The reduced-pressure bridge includes a delivery manifold operable to transfer the reduced pressure to the treatment manifold, an encapsulating envelope at least partially enclosing the delivery manifold and having a patient-facing side, and a reduced-pressure-interface site formed proximate one end of the reduced-pressure bridge.
-
公开(公告)号:US20240000616A1
公开(公告)日:2024-01-04
申请号:US18038365
申请日:2021-11-24
Applicant: AROA BIOSURGERY LIMITED
Inventor: Brian Roderick WARD , Isaac Tristram Tane MASON , Hamis Joshua ROSE , Alister Todd JOWSEY , Michael Andrew LOVELAND , Liam DOUGLAS , Samuel Barry TURNER , Brendan O'NEILL , Sean James GORMAN , Dorrin ASEFI , Henry David CHITTOCK
CPC classification number: A61F13/00068 , A61M1/92 , A61M1/91
Abstract: A device for implantation at a treatment site in the body of a patient for the removal of fluid from the treatment site. The device includes a conduit structure at least in part defining a fluid removal lumen, and a porous bioresorbable sheath surrounding a portion of the conduit structure. The conduit structure comprises a removable component configured for removal from the treatment site upon completion of treatment.
-
公开(公告)号:US11806468B2
公开(公告)日:2023-11-07
申请号:US16980970
申请日:2019-03-18
Applicant: T.J.Smith and Nephew, Limited
Inventor: Felix Clarence Quintanar
CPC classification number: A61M1/92 , A61M1/962 , G06F21/62 , A61M1/982 , A61M1/985 , A61M2205/276 , A61M2205/3331 , A61M2205/502
Abstract: Embodiments of secure wound therapy systems and methods for operating the systems are disclosed. In some embodiments, the apparatus includes a pressure source, a user interface, and a locking mechanism. The locking mechanism can be in one of at least two states, the at least two states including a first state in which the locking mechanism physically prevents user adjustment of one or more operational parameters with the user interface and a second state in which the locking mechanism does not physically prevent user adjustment of the one or more operational parameters with the user interface. The locking mechanism can include an authentication key and a receiver configured to receive an authentication input, which may be compared to the authentication key. Providing a sufficiently matching authentication input can transition the locking mechanism from the first state to the second state, permitting adjustments to the one or more operational parameters.
-
10.
公开(公告)号:US11806216B2
公开(公告)日:2023-11-07
申请号:US17259251
申请日:2019-07-08
Applicant: KCI Licensing, Inc.
Inventor: Christopher Brian Locke , Justin Alexander Long
CPC classification number: A61F13/00068 , A61M1/92 , A61M3/0254 , A61M39/10 , A61M39/24 , A61M2205/3331 , A61M2205/3389 , A61M2205/3569
Abstract: Systems, apparatuses, and methods for instilling fluid to a tissue site in a negative-pressure therapy environment are described, Illustrative embodiments may include a pneumatically-actuated instillation pump that can draw a solution from a solution source during a negative-pressure interval, and instill the solution to a dressing during a venting interval. In one example embodiment, a system for providing negative-pressure and instillation to a tissue site may comprise a negative-pressure device and an instillation device. The negative-pressure device may comprise a negative-pressure source and a controller electrically coupled to the negative-pressure source. The instillation device may comprise a dosing valve having a dosing chamber including a dosing outlet configured to be fluidly coupled to a fluid port and a dosing inlet configured to be fluidly coupled to a source of instillation solution. The dosing valve may also have a working chamber including a biasing element operably engaged to the dosing chamber and configured to be fluidly coupled to the negative-pressure source. In some embodiments of the system, the instillation device may further comprise a wireless transceiver configured to communicate with the controller, and at least one sensor coupled to the wireless transceiver to provide a signal indicative of an operating condition of the dosing valve, and wherein the wireless transceiver is configured to communicate the at least one signal to the controller.
-
-
-
-
-
-
-
-
-